261 Several PMO-based NADs have been approved for treating DMD, including eteplirsen (Exondys 51), 262 golodirsen (Vyondys 53 ), 80 viltolarsen (Viltepso ), 263 and casimersen (Amondys )
with if necessary, a number identifying the monomer isoform (e.g
D51.9 - Vitamin B12 deficiency anemia, unspecified: This code is for instances when B12 deficiency anemia is diagnosed, but its specific cause hasn't been determined
Jul 15, 2026 View our newsletter archive
Individual pharmacology and genetics: Variability in GLP-1 receptor signaling and metabolic response means some people are simply stronger or weaker responders
The retatrutide phase 2 body-composition substudy showed lean-mass loss in line with the total weight loss, without evidence of the medication causing extra lean mass losses